Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allos Pharma Inc.
Cambridge, Massachusetts, United Statesallospharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Allos Pharma is a late-stage pharmaceutical company focused on developing arbaclofen, a small molecule GABA-B receptor agonist, for rare neurological and neurodevelopmental disorders. The company has completed two Phase 3 trials of arbaclofen in Fragile X Syndrome with positive efficacy signals and is preparing for an NDA submission. Arbaclofen also showed promising results in clinical studies for Autism Spectrum Disorder, though primary endpoints were not met; further meta-analysis is planned. The company holds exclusive worldwide rights to develop and commercialize arbaclofen for these indications.[1][2][4]
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecules (notably arbaclofen, a GABA-B receptor agonist)[3][7]
- Industry
- Biotech
02
Partnerships
None specifically named; strong collaborations with patient advocacy groups such as the National Fragile X Foundation and FRAXA Research Foundation are noted.[7][8]
Beyond the preview
Go deeper on Allos Pharma Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allos Pharma Inc..